JOHNSON & JOHNSON is 524.8x more valuable than Wave Life Sciences Ltd. by market capitalization ($573.98 B vs $1.09 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | WVE | JNJ |
|---|---|---|
| Market cap | $1.09 B | $573.98 B |
| US-listed rank | #2576 | #20 |
| Revenue (latest FY) | $42.73M | $94.19B |
| Net income (latest FY) | -$204.38M | $26.80B |
| Net margin | -478.3% | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 695 | 984 |
JOHNSON & JOHNSON is 524.8x more valuable than Wave Life Sciences Ltd. by market capitalization ($573.98 B vs $1.09 B).
In their latest fiscal years, Wave Life Sciences Ltd. reported $42.73M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Wave Life Sciences Ltd. and JOHNSON & JOHNSON, or browse the full rankings.